|
PMVP PMV Pharmaceuticals Inc 1699382 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-18,038,000.00 |
| Balance Sheet |
|
Current Assets
|
$95,780,000.00 |
|
Assets
|
$96,562,000.00 |
|
Current Liabilities
|
$8,595,000.00 |
|
Liabilities
|
$8,595,000.00 |
|
Equity
|
$87,967,000.00 |
|
Shares Out
|
53331766.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-19,679,000.00 |
|
Investing Cash Flow
|
$20,824,000.00 |
| Market Analysis |
Market Cap
|
$60,264,895.58 |
|
Price
|
$1.12 |
|
BVPS
|
1.65 |
|
PB
|
0.68 |
|
EPS
|
-0.34 |
|
FCF
|
$-19,679,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:38 |
|
| Apr |
May |
Jun |
| 2026-03-06 |
-1.48 |
|
|
2026-05-12 |
-0.34 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.40 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PMVP documents filed with the SEC.
PMVP Filings
Clear
